Cel-Sci CorpAdd to My Watchlist

CVM:USNYSE MKT LLCIndustry: Medical-Biomedical/Gene
  • 1.22
    Last
  • 0.05  -3.94%
    Today's Change
  • 1.27
    Previous Close
  • Today
     
    0.53
    3.09
    52 Week Low - High
8:04 pm ET 4/24/2014
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding67 million
Market Cap$82 million
Return on Equity ttm-132.75%
Last DividendCVM:US does not pay a dividend
Earnings
EPS: Year Actual ttm-0.610
EPS: Year Est. 9/14 ttm-0.470
 
EPS: Quarterly Actual 12/13 -0.13
EPS: Quarterly Est. 3/14 -0.12
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate57.14
Company Description
CEL-SCI Corporation researches and develops certain drugs and vaccines. The Company's Multikine is being tested to determine if it is effective in improving the immune response of cancer patients. CEL-SCI is also developing other products. The Company is currently targeting diseases such as AIDS, herpes simplex, malaria, tuberculosis, prostate cancer, and breast cancer.
Revenue$159,580
Net Income$-9 million
Total Assets$11 million
Employees44
Web Sitewww.cel-sci.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!